Strategic partnerships Segal Trials has recently entered a strategic partnership with Cybin for a multinational pivotal Phase 3 program targeting Major Depressive Disorder, presenting a potential co-management or referral opportunity in psychiatry research and CNS drug development.

Geographic expansion With seven research sites across South Florida and a history of launching new facilities such as Miami Lakes Medical Research, there is potential to expand site network partnerships, site management collaboration, or regional CRO support for multi-site trials.

Therapeutic focus Core emphasis on psychiatry, neurology, addiction, sleep, general medicine, infectious diseases, vaccines, and women's health suggests opportunities to target sponsors with CNS and neuropsychiatry pipelines, including early-phase to late-stage trials.

Operational readiness A team of over 110 professionals supporting 51-200 employees indicates scalable trial operations capability, which can be leveraged for sponsor programs requiring agile recruitment, patient advocacy, and high-quality data across multiple phases.

Digital and patient-centric Adoption of diverse tech stack including HubSpot, Google/Reddit ads, Microsoft Clarity, Drift, and Stripe signals strong digital engagement, potential to offer patient recruitment optimization, site performance analytics, and streamlined sponsor communications.